Zobrazeno 1 - 10
of 454
pro vyhledávání: '"Vilas-Zornoza A"'
Autor:
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda, Nahia Gómez-Echarte, Fernando García, Stella Charalampopoulou, Elena Sáez, Amaia Vilas-Zornoza, Patxi San Martín-Uriz, Luis V. Valcárcel, Naroa Barrena, Diego Alignani, Luis Esteban Tamariz-Amador, Ana Pérez-Ruiz, Sebastian Hilscher, Mike Schutkowski, Ana Alfonso-Pierola, Nicolás Martinez-Calle, María José Larrayoz, Bruno Paiva, María José Calasanz, Javier Muñoz, Marta Isasa, José Ignacio Martin-Subero, Antonio Pineda-Lucena, Julen Oyarzabal, Xabier Agirre, Felipe Prósper
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-23 (2024)
Abstract Despite the development of novel therapies for acute myeloid leukemia, outcomes remain poor for most patients, and therapeutic improvements are an urgent unmet need. Although treatment regimens promoting differentiation have succeeded in the
Externí odkaz:
https://doaj.org/article/c19f4277205c445384d53303bce19ff2
Autor:
Guillermo Serrano, Nerea Berastegui, Aintzane Díaz-Mazkiaran, Paula García-Olloqui, Carmen Rodriguez-Res, Sofia Huerga-Dominguez, Marina Ainciburu, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Paula Aguirre-Ruiz, Asier Ullate-Agote, Beñat Ariceta, Jose-Maria Lamo-Espinosa, Pamela Acha, Oriol Calvete, Tamara Jimenez, Antonieta Molero, Maria Julia Montoro, Maria Díez-Campelo, David Valcarcel, Francisco Solé, Ana Alfonso-Pierola, Idoia Ochoa, Felipe Prósper, Teresa Ezponda, Mikel Hernaez
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract While myelodysplastic syndromes with del(5q) (del(5q) MDS) comprises a well-defined hematological subgroup, the molecular basis underlying its origin remains unknown. Using single cell RNA-seq (scRNA-seq) on CD34+ progenitors from del(5q) MD
Externí odkaz:
https://doaj.org/article/91536052d5734ebda987ce77dddb892b
Autor:
Palacios-Berraquero, Maria Luisa, Rodriguez-Marquez, Paula, Calleja-Cervantes, Maria Erendira, Berastegui, Nerea, Zabaleta, Aintzane, Burgos, Leire, Alignani, Diego, San Martin-Uriz, Patxi, Vilas-Zornoza, Amaia, Rodriguez-Diaz, Saray, Inoges, Susana, Lopez-Diaz de Cerio, Ascensión, Huerga, Sofia, Tamariz, Esteban, Rifon, Jose, Alfonso-Pierola, Ana, Lasarte, Juan Jose, Paiva, Bruno, Hernaez, Mikel, Rodriguez-Otero, Paula, San-Miguel, Jesus, Ezponda, Teresa, Rodriguez-Madoz, Juan Roberto, Prosper, Felipe
Publikováno v:
In Blood Advances 12 November 2024 8(21):5479-5492
Autor:
Massoni-Badosa, Ramon, Aguilar-Fernández, Sergio, Nieto, Juan C., Soler-Vila, Paula, Elosua-Bayes, Marc, Marchese, Domenica, Kulis, Marta, Vilas-Zornoza, Amaia, Bühler, Marco Matteo, Rashmi, Sonal, Alsinet, Clara, Caratù, Ginevra, Moutinho, Catia, Ruiz, Sara, Lorden, Patricia, Lunazzi, Giulia, Colomer, Dolors, Frigola, Gerard, Blevins, Will, Romero-Rivero, Lucia, Jiménez-Martínez, Víctor, Vidal, Anna, Mateos-Jaimez, Judith, Maiques-Diaz, Alba, Ovejero, Sara, Moreaux, Jérôme, Palomino, Sara, Gomez-Cabrero, David, Agirre, Xabier, Weniger, Marc A., King, Hamish W., Garner, Lucy C., Marini, Federico, Cervera-Paz, Francisco Javier, Baptista, Peter M., Vilaseca, Isabel, Rosales, Cecilia, Ruiz-Gaspà, Silvia, Talks, Benjamin, Sidhpura, Keval, Pascual-Reguant, Anna, Hauser, Anja E., Haniffa, Muzlifah, Prosper, Felipe, Küppers, Ralf, Gut, Ivo Glynne, Campo, Elias, Martin-Subero, José Ignacio, Heyn, Holger
Publikováno v:
In Immunity 13 February 2024 57(2):379-399
Autor:
José Calasanz María, Prósper Felipe, Rodríguez-Otero Paula, Vilas-Zornoza Amaia, Cordeu Lucia, Martin Vanesa, Garate Leire, Jiménez-Velasco Antonio, Román-Gómez José, San José-Enériz Edurne, Agirre Xabier
Publikováno v:
Molecular Cancer, Vol 8, Iss 1, p 69 (2009)
Abstract The development of Imatinib Mesylate (IM), the first specific inhibitor of BCR-ABL1, has had a major impact in patients with Chronic Myeloid Leukemia (CML), establishing IM as the standard therapy for CML. Despite the clinical success obtain
Externí odkaz:
https://doaj.org/article/21f0c8efa77e4c5aa57b7a2556ae0829
Autor:
Marta Moya-Jódar, Asier Ullate-Agote, Paula Barlabé, Juan Roberto Rodríguez-Madoz, Gloria Abizanda, Carolina Barreda, Xonia Carvajal-Vergara, Amaia Vilas-Zornoza, Juan Pablo Romero, Leire Garate, Xabier Agirre, Giulia Coppiello, Felipe Prósper, Xabier L. Aranguren
Publikováno v:
Stem Cell Reports, Vol 18, Iss 1, Pp 64-80 (2023)
Summary: Naive human pluripotent stem cells (hPSCs) are defined as the in vitro counterpart of the human preimplantation embryo’s epiblast and are used as a model system to study developmental processes. In this study, we report the discovery and c
Externí odkaz:
https://doaj.org/article/5525088ab778485bae0f0d5d92dd1f1f
Autor:
Nerea Berastegui, Marina Ainciburu, Juan P. Romero, Paula Garcia-Olloqui, Ana Alfonso-Pierola, Céline Philippe, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Raquel Ruiz-Hernández, Ander Abarrategi, Raquel Ordoñez, Diego Alignani, Sarai Sarvide, Laura Castro-Labrador, José M. Lamo-Espinosa, Mikel San-Julian, Tamara Jimenez, Félix López-Cadenas, Sandra Muntion, Fermin Sanchez-Guijo, Antonieta Molero, Maria Julia Montoro, Bárbara Tazón, Guillermo Serrano, Aintzane Diaz-Mazkiaran, Mikel Hernaez, Sofía Huerga, Findlay Bewicke-Copley, Ana Rio-Machin, Matthew T. Maurano, María Díez-Campelo, David Valcarcel, Kevin Rouault-Pierre, David Lara-Astiaso, Teresa Ezponda, Felipe Prosper
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Myelodysplastic syndromes (MDS) are age-related pathologies in which alterations of hematopoietic stem cells lead to abnormal formation of blood cells. Here, the authors study the lesions that these cells undergo in aging and disease, characterizing
Externí odkaz:
https://doaj.org/article/5a52f5ed769d4553afa3673e2f1e7052
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.